Vest N, Sox-Harris A, Ilgen M, Humphreys K, Timko C
Alcohol Clin Exp Res. 2020; 44(12):2570-2578.
PMID: 33104268
PMC: 7863278.
DOI: 10.1111/acer.14474.
Hides L, Quinn C, Stoyanov S, Kavanagh D, Baker A
Cochrane Database Syst Rev. 2019; 2019(11).
PMID: 31769015
PMC: 6953216.
DOI: 10.1002/14651858.CD009501.pub2.
Moore A, Lake J, Glasner S, Karlamangla A, Kuerbis A, Preciado D
J Subst Abuse Treat. 2019; 100:29-38.
PMID: 30898325
PMC: 6432935.
DOI: 10.1016/j.jsat.2019.02.003.
Myers U, Browne K, Norman S
J Dual Diagn. 2015; 11(3-4):238-47.
PMID: 26515712
PMC: 4915366.
DOI: 10.1080/15504263.2015.1113762.
Worley M, Trim R, Tate S, Roesch S, Myers M, Brown S
Psychol Addict Behav. 2014; 28(4):1220-9.
PMID: 25347018
PMC: 4651972.
DOI: 10.1037/a0037901.
Cognitive behavioral therapy: a meta-analysis of race and substance use outcomes.
Windsor L, Jemal A, Alessi E
Cultur Divers Ethnic Minor Psychol. 2014; 21(2):300-13.
PMID: 25285527
PMC: 4589258.
DOI: 10.1037/a0037929.
Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?.
Paddock S, Hunter S, Leininger T
J Subst Abuse Treat. 2014; 47(1):78-85.
PMID: 24657006
PMC: 4011957.
DOI: 10.1016/j.jsat.2014.02.005.
Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.
Worley M, Tate S, Granholm E, Brown S
J Consult Clin Psychol. 2014; 82(3):418-28.
PMID: 24588403
PMC: 4651969.
DOI: 10.1037/a0036033.
Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis.
Riper H, Andersson G, Hunter S, De Wit J, Berking M, Cuijpers P
Addiction. 2013; 109(3):394-406.
PMID: 24304463
PMC: 4227588.
DOI: 10.1111/add.12441.
12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model.
Worley M, Tate S, McQuaid J, Granholm E, Brown S
Subst Abus. 2013; 34(1):43-50.
PMID: 23327503
PMC: 3558836.
DOI: 10.1080/08897077.2012.691451.
Treatment of the depressed alcoholic patient.
DeVido J, Weiss R
Curr Psychiatry Rep. 2012; 14(6):610-8.
PMID: 22907336
PMC: 3712746.
DOI: 10.1007/s11920-012-0314-7.
A Combined Group and Individual 12-Step Facilitative Intervention Targeting Stimulant Abuse in the NIDA Clinical Trials Network: STAGE-12.
Daley D, Stuart Baker M, Donovan D, Hodgkins C, Perl H
J Groups Addict Recover. 2012; 6(3):228-244.
PMID: 22859917
PMC: 3408890.
DOI: 10.1080/1556035X.2011.597196.
Do client attributes moderate the effectiveness of a group cognitive behavioral therapy for depression in addiction treatment?.
Hunter S, Paddock S, Zhou A, Watkins K, Hepner K
J Behav Health Serv Res. 2012; 40(1):57-70.
PMID: 22828976
PMC: 3729474.
DOI: 10.1007/s11414-012-9289-8.
Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression.
Worley M, Tate S, Brown S
Addiction. 2012; 107(11):1974-83.
PMID: 22578037
PMC: 3466338.
DOI: 10.1111/j.1360-0443.2012.03943.x.
Study protocol: a randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment.
Kelly P, Kay-Lambkin F, Baker A, Deane F, Brooks A, Mitchell A
BMC Public Health. 2012; 12:113.
PMID: 22325594
PMC: 3306755.
DOI: 10.1186/1471-2458-12-113.
Clinical outcomes of an integrated treatment for depression and substance use disorders.
Lydecker K, Tate S, Cummins K, McQuaid J, Granholm E, Brown S
Psychol Addict Behav. 2010; 24(3):453-65.
PMID: 20853931
PMC: 3609717.
DOI: 10.1037/a0019943.
Service utilization during and after outpatient treatment for comorbid substance use disorder and depression.
Worley M, Trim R, Tate S, Hall J, Brown S
J Subst Abuse Treat. 2010; 39(2):124-31.
PMID: 20598832
PMC: 5758480.
DOI: 10.1016/j.jsat.2010.05.009.
Self-efficacy mediates the relationship between depression and length of abstinence after treatment among youth but not among adults.
Ramo D, Myers M, Brown S
Subst Use Misuse. 2010; 45(13):2301-22.
PMID: 20388012
PMC: 3031168.
DOI: 10.3109/10826081003710304.
Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?.
Brewer J, Bowen S, Smith J, Marlatt G, Potenza M
Addiction. 2010; 105(10):1698-706.
PMID: 20331548
PMC: 2905496.
DOI: 10.1111/j.1360-0443.2009.02890.x.
Psychopathology in methamphetamine-dependent adults 3 years after treatment.
Glasner-Edwards S, Mooney L, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R
Drug Alcohol Rev. 2010; 29(1):12-20.
PMID: 20078677
PMC: 3772133.
DOI: 10.1111/j.1465-3362.2009.00081.x.